Down syndrome gene dosage imbalance on cerebellum development

Progress in Neurobiology

Volumn 82, Issue 2, 2007, Pages 87-94

  Moldrich, Randal X ^a   Dauphinot, Luce ^a   Laffaire, Julien ^a   Rossier, Jean ^a   Potier, Marie Claude ^a  

^a Brain Plasticity Unit   (France)

Author keywords

Cerebellum; Down syndrome; Granule cells; Mitosis; Purkinje neurons; Shh; Sonic hedgehog; Ts1Cje; Ts65Dn

Indexed keywords

BRAIN DEVELOPMENT; CELL PROLIFERATION; CEREBELLUM; DOWN SYNDROME; GENE DOSAGE; GENE EXPRESSION; HUMAN; MOTOR CONTROL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CEREBELLUM; DISEASE MODELS, ANIMAL; DOWN SYNDROME; GENE DOSAGE; HUMANS; MICE;

EID: 34249744493     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2007.02.006     Document Type: Review

References (67)

1. Altafaj X., Dierssen M., Baamonde C., Marti E., Visa J., Guimera J., Oset M., Gonzalez J.R., Florez J., Fillat C., and Estivill X. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum. Mol. Genet. 10 (2001) 1915-1923
2. Amano K., Sago H., Uchikawa C., Suzuki T., Kotliarova S.E., Nukina N., Epstein C.J., and Yamakawa K. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Hum. Mol. Genet. 13 (2004) 1333-1340
3. Antonarakis S.E., Lyle R., Dermitzakis E.T., Reymond A., and Deutsch S. Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat. Rev. Genet. 5 (2004) 725-738
4. Argenti B., Gallo R., Di Marcotullio L., Ferretti E., Napolitano M., Canterini S., De Smaele E., Greco A., Fiorenza M.T., Maroder M., Screpanti I., Alesse E., and Gulino A. Hedgehog antagonist REN(KCTD11) regulates proliferation and apoptosis of developing granule cell progenitors. J. Neurosci. 25 (2005) 8338-8346
5. Arron J.R., Winslow M.M., Polleri A., Chang C.P., Wu H., Gao X., Neilson J.R., Chen L., Heit J.J., Kim S.K., Yamasaki N., Miyakawa T., Francke U., Graef I.A., and Crabtree G.R. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441 (2006) 595-600
6. Aylward E.H., Habbak R., Warren A.C., Pulsifer M.B., Barta P.E., Jerram M., and Pearlson G.D. Cerebellar volume in adults with Down syndrome. Arch. Neurol. 54 (1997) 209-212
7. Barbiero L., Benussi L., Ghidoni R., Alberici A., Russo C., Schettini G., Pagano S.F., Parati E.A., Mazzoli F., Nicosia F., Signorini S., Feudatari E., and Binetti G. BACE-2 is overexpressed in Down's syndrome. Exp. Neurol. 182 (2003) 335-345
8. Baxter L.L., Moran T.H., Richtsmeier J.T., Troncoso J., and Reeves R.H. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum. Mol. Genet. 9 (2000) 195-202
9. Becker W., and Joost H.G. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog. Nucleic Acid Res. Mol. Biol. 62 (1999) 1-17
10. Benedito A.B., Lehtinen M., Massol R., Lopes U.G., Kirchhausen T., Rao A., and Bonni A. The transcription factor NFAT3 mediates neuronal survival. J. Biol. Chem. 280 (2005) 2818-2825
11. Blaess S., Graus-Porta D., Belvindrah R., Radakovits R., Pons S., Littlewood-Evans A., Senften M., Guo H., Li Y., Miner J.H., Reichardt L.F., and Muller U. Beta1-integrins are critical for cerebellar granule cell precursor proliferation. J. Neurosci. 24 (2004) 3402-3412
12. Brodsky G., Barnes T., Bleskan J., Becker L., Cox M., and Patterson D. The human GARS-AIRS-GART gene encodes two proteins which are differentially expressed during human brain development and temporally overexpressed in cerebellum of individuals with Down syndrome. Hum. Mol. Genet. 6 (1997) 2043-2050
13. Bustin M., Alfonso P.J., Pash J.M., Ward J.M., Gearhart J.D., and Reeves R.H. Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin. DNA Cell Biol. 14 (1995) 997-1005
14. Chrast R., Scott H.S., Papasavvas M.P., Rossier C., Antonarakis E.S., Barras C., Davisson M.T., Schmidt C., Estivill X., Dierssen M., Pritchard M., and Antonarakis S.E. The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res. 10 (2000) 2006-2021
15. Christianson A.L., Howson C.P., and Modell B. Global Report on birth defects: The hidden toll of dying and disabled children (2006), March of Dimes Birth Defects Foundation, White Plains, NY pp. 98
16. Dauphinot L., Lyle R., Rivals I., Dang M.T., Moldrich R.X., Golfier G., Ettwiller L., Toyama K., Rossier J., Personnaz L., Antonarakis S.E., Epstein C.J., Sinet P.M., and Potier M.C. The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. Hum. Mol. Genet. 14 (2005) 373-384
17. Davisson M.T., Schmidt C., Reeves R.H., Irving N.G., Akeson E.C., Harris B.S., and Bronson R.T. Segmental trisomy as a mouse model for Down syndrome. Prog. Clin. Biol. Res. 384 (1993) 117-133
18. de la Luna S., and Estivill X. Cooperation to amplify gene-dosage-imbalance effects. Trends Mol. Med. 12 (2006) 451-454
19. Epstein C.J. Down's syndrome: critical genes in a critical region. Nature 441 (2006) 582-583
20. Ermak G., Harris C.D., and Davies K.J. The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress. Faseb J. 16 (2002) 814-824
21. Escorihuela R.M., Vallina I.F., Martinez-Cue C., Baamonde C., Dierssen M., Tobena A., Florez J., and Fernandez-Teruel A. Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome. Neurosci. Lett. 247 (1998) 171-174
22. Fuentes J.J., Genesca L., Kingsbury T.J., Cunningham K.W., Perez-Riba M., Estivill X., and de la Luna S. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum. Mol. Genet. 9 (2000) 1681-1690
23. Gardiner K., Fortna A., Bechtel L., and Davisson M.T. Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 318 (2003) 137-147
24. Grinberg I., Northrup H., Ardinger H., Prasad C., Dobyns W.B., and Millen K.J. Heterozygous deletion of the linked genes ZIC1 and ZIC4 is involved in Dandy-Walker malformation. Nat. Genet. 36 (2004) 1053-1055
25. Gwack Y., Sharma S., Nardone J., Tanasa B., Iuga A., Srikanth S., Okamura H., Bolton D., Feske S., Hogan P.G., and Rao A. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441 (2006) 646-650
26. Harashima C., Jacobowitz D.M., Stoffel M., Chakrabarti L., Haydar T.F., Siarey R.J., and Galdzicki Z. Elevated Expression of the G-Protein-Activated Inwardly Rectifying Potassium Channel 2 (GIRK2) in Cerebellar Unipolar Brush Cells of a Down Syndrome Mouse Model. Cell Mol. Neurobiol. 26 (2006) 719-734
27. Hook E.B., Cross P.K., and Schreinemachers D.M. Chromosomal abnormality rates at amniocentesis and in live-born infants. Jama 249 (1983) 2034-2038
28. Hyde L.A., Crnic L.S., Pollock A., and Bickford P.C. Motor learning in Ts65Dn mice, a model for Down syndrome. Dev. Psychobiol. 38 (2001) 33-45
29. Kenney A.M., Cole M.D., and Rowitch D.H. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 130 (2003) 15-28
30. Kluetzman K.S., Perez A.V., and Crawford D.R. DSCR1 (ADAPT78) lethality: evidence for a protective effect of trisomy 21 genes?. Biochem. Biophys. Res. Commun. 337 (2005) 595-601
31. Latash M.L., and Corcos D.M. Kinematic and electromyographic characteristics of single-joint movements of individuals with Down syndrome. Am. J. Ment. Retard. 96 (1991) 189-201
32. Latash M.L., Kang N., and Patterson D. Finger coordination in persons with Down syndrome: atypical patterns of coordination and the effects of practice. Exp. Brain Res. 146 (2002) 345-355
33. Lee E.B., Zhang B., Liu K., Greenbaum E.A., Doms R.W., Trojanowski J.Q., and Lee V.M. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo. J. Cell Biol. 168 (2005) 291-302
34. Lejeune J., Turpin R., and Gautier M. Chromosomic diagnosis of mongolism. Arch. Fr. Pediatr. 16 (1959) 962-963
35. Lejeune J., Turpin R., and Gautier M. Mongolism; a chromosomal disease (trisomy). Bull. Acad. Natl. Med. 143 (1959) 256-265
36. Lorenzi H.A., and Reeves R.H. Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res. 1104 (2006) 153-159
37. Lyle R., Cehrig C., Neergaard-Henrichsen C., Deutsch S., and Antonarakis S.E. Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome. Genome Res. 12 (2004) 2013-2019
38. Mao R., Wang X., Spitznagel E.L., Frelin L.P., Ting J.C., Ding H., Kim J.-W., Ruczinski I., Downey T.J., and Pevsner J. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol. 6 (2005) R107
39. Mills J., Niewmierzycka A., Oloumi A., Rico B., St-Arnaud R., Mackenzie I.R., Mawji N.M., Wilson J., Reichardt L.F., and Dedhar S. Critical role of integrin-linked kinase in granule cell precursor proliferation and cerebellar development. J. Neurosci. 26 (2006) 830-840
40. Moore C. Postnatal Lethality and Cardiac Anomalies in the Ts65Dn Down Syndrome Mouse Model. Mamm. Genome 17 (2006) 1005-1012
41. Nakagawa M., Ichikawa M., Kumano K., Goyama S., Kawazu M., Asai T., Ogawa S., Kurokawa M., and Chiba S. AML1/Runx1 rescues Notch1-Null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis. Blood 108 (2006) 3329-3334
42. O'Doherty A., Ruf S., Mulligan C., Hildreth V., Errington M.L., Cooke S., Sesay A., Modino S., Vanes L., Hernandez D., Linehan J.M., Sharpe P.T., Brandner S., Bliss T.V., Henderson D.J., Nizetic D., Tybulewicz V.L., and Fisher E.M. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309 (2005) 2033-2037
43. Ohta M., Kitamoto T., Iwaki T., Ohgami T., Fukui M., and Tateishi J. Immunohistochemical distribution of amyloid precursor protein during normal rat development. Brain Res. Dev. Brain Res. 75 (1993) 151-161
44. Olson L.E., Roper R.J., Baxter L.L., Carlson E.J., Epstein C.J., and Reeves R.H. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev. Dyn. 230 (2004) 581-589
45. Palma V., and Ruiz i Altaba A. Hedgehog-GLI signaling regulates the behaviour of cells with stem cell properties in the developing neocortex. Development 131 (2004) 337-345
46. Park H.L., Bai C., Platt K.A., Matise M.P., Beeghly A., Hui C.C., Nakashima M., and Joyner A.L. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127 (2000) 1593-1605
47. Philip N., Chabrol B., Lossi A.M., Cardoso C., Guerrini R., Dobyns W.B., Raybaud C., and Villard L. Mutations in the oligophrenin-1 gene (OPHN1) cause X linked congenital cerebellar hypoplasia. J. Med. Genet. 40 (2003) 441-446
48. Pinter J.D., Eliez S., Schmitt J.E., Capone G.T., and Reiss A.L. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am. J. Psychiatry 158 (2001) 1659-1665
49. Potier M.C., Rivals I., Mercier G., Ettwiller L., Moldrich R.X., Laffaire J., Personnaz L., Rossier J., and Dauphinot L. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development. J. Neurochem. 97 Suppl. 11 (2006) 104-109
50. Roizen N.J., and Patterson D. Down's syndrome. Lancet 361 (2003) 1281-1289
51. Roper R.J., Baxter L.L., Saran N.G., Klinedinst D.K., Beachy P.A., and Reeves R.H. Defective cerebellar response to mitogenic Hedgehog signaling in Down syndrome mice. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 1452-1456
52. Roper R.J., and Reeves R.H. Understanding the basis for Down syndrome phenotypes. PLoS Genet. 2 (2006) e50
53. Ruiz i Altaba A. Gli proteins and Hedgehog signaling: development and cancer. Trends Genet. 15 (1999) 418-425
54. Ryman D., and Lamb B.T. Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse. Curr. Alzheimer Res. 3 (2006) 465-473
55. Sago H., Carlson E.J., Smith D.J., Rubin E.M., Crnic L.S., Huang T.T., and Epstein C.J. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res. 48 (2000) 606-613
56. Salehi A., Delacroix J.D., Belichenko P.V., Zhan K., Wu C., Valletta J.S., Takimoto-Kimura R., Kleschevnikov A.M., Sambamurti K., Chung P.P., Xia W., Villar A., Campbell W.A., Kulnane L.S., Nixon R.A., Lamb B.T., Epstein C.J., Stokin G.B., Goldstein L.S., and Mobley W.C. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51 (2006) 29-42
57. Saran N.G., Pletcher M.T., Natale J.E., Cheng Y., and Reeves R.H. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum. Mol. Genet. 12 (2003) 2013-2019
58. Sato M., Suzuki K., Yamazaki H., and Nakanishi S. A pivotal role of calcineurin signaling in development and maturation of postnatal cerebellar granule cells. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5874-5879
59. Seregaza Z., Roubertoux P.L., Jamon M., and Soumireu-Mourat B. Mouse models of cognitive disorders in trisomy 21: a review. Behav. Genet. 36 (2006) 387-404
60. Shapiro B.L. Developmental instability of the cerebellum and its relevance to Down syndrome. J. Neural. Transm. Suppl. (2001) 11-34
61. Simons M.J., and Pellionisz A.J. Genomics, morphogenesis and biophysics: triangulation of Purkinje cell development. Cerebellum 5 (2006) 27-35
62. Smith D.J., Stevens M.E., Sudanagunta S.P., Bronson R.T., Makhinson M., Watabe A.M., O'Dell T.J., Fung J., Weier H.U., Cheng J.F., and Rubin E.M. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat. Genet. 16 (1997) 28-36
63. Solecki D.J., Liu X.L., Tomoda T., Fang Y., and Hatten M.E. Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron 31 (2001) 557-568
64. Sotelo C. Cellular and genetic regulation of the development of the cerebellar system. Prog. Neurobiol. 72 (2004) 295-339
65. Suda S., Nibuya M., Suda H., Takamatsu K., Miyazaki T., Nomura S., and Kawai N. Potassium channel mRNAs with AU-rich elements and brain-specific expression. Biochem. Biophys. Res. Commun. 291 (2002) 1265-1271
66. Villar A.J., Belichenko P.V., Gillespie A.M., Kozy H.M., Mobley W.C., and Epstein C.J. Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. Mamm. Genome 16 (2005) 79-90
67. Weller M., Krautler N., Mantei N., Suter U., and Taylor V. Jagged1 ablation results in cerebellar granule cell migration defects and depletion of Bergmann glia. Dev. Neurosci. 28 (2006) 70-80